Congenica Neuro facilitates simplified and accurate identification, review and reporting of de novo variants from a set of expert-curated genes associated with neurodevelopmental disorders and disorders characterized by isolated or syndromic early onset epilepsy
Copyright © 2022 Congenica Ltd, Company number: 8273616 Registered in England and Wales
Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.